Fundraising FoxRobin Hood Ventures — 2016 Investments
4 investments dated 2016 · listed companies and verified rows first · show all
QR Pharma is a clinical-stage biopharmaceutical company developing buntanetap, an orally administered small molecule that inhibits the synthesis of multiple neurotoxic proteins implicated in Alzheimer's disease and Parkinson's disease.
BiotechBerwyn, US
Maria Maccecchini(Executive Officer, Director)
BoardDhesh Govender(Director)Michael Hoffman(Director)Franz F. Hefti(Director)
Co-investorsKeiretsu ForumBen Franklin Technology PartnersBioAdvance
ARC is a device management system that tracks, charges, and maintains shared enterprise devices like smartphones, tablets, and scanners.
Enterprise SoftwareHardwareIoTSaaSPhiladelphia, US
Douglas BaldasareinRobert Kay(Executive Officer)inHarsh Agarwal(Executive Officer, Director)Peter Schmitt(Executive Officer, Director)
PartnerPitou Devgon· solo GP
Co-investorsaVentureFusionX VenturesSoundboard Venture FundStart CapitalTIA Ventures
BiologicsMD is a preclinical therapeutic company developing patent-protected recombinant fusion proteins that target the parathyroid hormone receptor for treatments in hair loss, bone disorders, and oncology.
BiotechHealthtechFayetteville, US
J. David Owens(Executive Officer, Director)Robyn Goforth(Executive Officer)Rob Gensure(Executive Officer)
BoardRamsay Ball(Director)Calvin Goforth(Director, Promoter)Lynn Kirkpatrick(Director)
PartnerPitou Devgon· solo GP
Co-investorsConnecticut InnovationsHouston Angel Network
LoanLogics provides mortgage technology for lenders, correspondent investors, and fintech/LOS/POS/BPO providers, including tools that convert unstructured mortgage documents into verified loan data (IDEA), calculate and validate borrower income (LoanBeam), and automate loan quality control and defect detection (LoanHD).
AI & Machine LearningFintechSaaSTrevose, US
Howard Conyack, Jr.(Executive Officer, Director)in"Jean Luc ""John""" Alarcon(Executive Officer)Joseph Helfrich(Executive Officer)Allen Pollack(Executive Officer)in"JL ""John""" Alarcon(Executive Officer)inBrian Fitzpatrick(Executive Officer, Director)
Co-investorsVolition CapitalBlue Cloud Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.